Skip to main content
SpringerLink
Log in

Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC

  • Chapter
  • First Online:
HPV Infection in Head and Neck Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 206))

  • 1727 Accesses

Abstract

Over the last three decades, it has become clear that infection with high-risk human papillomavirus (HPV) is etiologically linked to the development of head and neck squamous cell carcinomas, particularly those carcinomas that arise in the oropharyngeal region.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760

    Article  CAS  PubMed  Google Scholar 

  • Begum S, Westra WH (2008) Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol 32:1044–1050

    Article  PubMed  Google Scholar 

  • Butz K, Geisen C, Ullmann A et al (1996) Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer 68:506–513

    Article  CAS  PubMed  Google Scholar 

  • Chang AR, Wu HG, Park CI et al (2008) Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer. Head Neck 30:852–857

    Article  PubMed  Google Scholar 

  • Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301

    Article  PubMed  PubMed Central  Google Scholar 

  • Dahlstrom KR, Calzada G, Hanby JD, et al (2012) An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer

    Google Scholar 

  • de Jong MC, Pramana J, Van Der Wal JE et al (2010) CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 16:5329–5338

    Article  PubMed  Google Scholar 

  • Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269

    Article  CAS  PubMed  Google Scholar 

  • Fischer C, Zlobec I, Stockli E et al (2008) Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas. Hum Pathol 39:1527–1534

    Article  CAS  PubMed  Google Scholar 

  • Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720

    Article  CAS  PubMed  Google Scholar 

  • Gillison ML, D’Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407–420

    Article  PubMed  Google Scholar 

  • Granata R, Miceli R, Orlandi E et al (2012) Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 23:1832–1837

    Article  CAS  PubMed  Google Scholar 

  • Hafkamp HC, Manni JJ, Haesevoets A et al (2008) Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 122:2656–2664

    Article  CAS  PubMed  Google Scholar 

  • Hong A, Dobbins T, Lee CS et al (2010) Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 46:2088–2096

    Article  CAS  PubMed  Google Scholar 

  • Huang SH, Perez-Ordonez B, Liu FF et al (2012) Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 82:276–283

    Article  PubMed  Google Scholar 

  • Kallogjeri D, Piccirillo JF, Spitznagel EL Jr et al (2012) Comparison of scoring methods for ACE-27: simpler is better. J Geriatr Oncol 3:238–245

    Article  PubMed  PubMed Central  Google Scholar 

  • Kaplan MH, Feinstein AR (1974) The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27:387–404

    Article  CAS  PubMed  Google Scholar 

  • Kong CS, Narasimhan B, Cao H et al (2009) The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 74:553–561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lindel K, Beer KT, Laissue J et al (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92:805–813

    Article  CAS  PubMed  Google Scholar 

  • Lindquist D, Romanitan M, Hammarstedt L et al (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1:350–355

    Article  PubMed  Google Scholar 

  • Martens-de Kemp SR, Brink A, Stigter-van WM et al (2013) CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. Stem Cell Res 10:477–488

    Google Scholar 

  • Murphy CT, Devarajan K, Wang LS et al (2015) Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncol 51:1034–1040

    Article  PubMed  Google Scholar 

  • Nasman A, Attner P, Hammarstedt L et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366

    Article  PubMed  Google Scholar 

  • O’Sullivan B, Huang SH, Perez-Ordonez B et al (2012) Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 103:49–56

    Article  PubMed  Google Scholar 

  • O’Sullivan B, Huang SH, Siu LL et al (2013) Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31:543–550

    Article  PubMed  Google Scholar 

  • Perrone F, Gloghini A, Cortelazzi B et al (2011) Isolating p16-positive/HPV-negative oropharyngeal cancer: an effort worth making. Am J Surg Pathol 35:774–777

    Article  PubMed  Google Scholar 

  • Posner MR, Lorch JH, Goloubeva O et al (2011) Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 22:1071–1077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Putti TC, To KF, Hsu HC et al (2002) Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 41:144–151

    Article  CAS  PubMed  Google Scholar 

  • Rietbergen MM, Leemans CR, Bloemena E et al (2013a) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565–1571

    Article  CAS  PubMed  Google Scholar 

  • Rietbergen MM, Brakenhoff RH, Bloemena E et al (2013b) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24:2740–2745

    Article  CAS  PubMed  Google Scholar 

  • Rietbergen MM, Martens-de Kemp SR, Bloemena E et al (2014) Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer. Eur J Cancer 50:765–773

    Google Scholar 

  • Rietbergen MM, Witte BI, Velazquez ER et al (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112:1733–1736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rios VE, Hoebers F, Aerts HJ et al (2014) Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. Radiother Oncol 113:324–330

    Article  Google Scholar 

  • Rischin D, Young RJ, Fisher R et al (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28:4142–4148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shaw R, Robinson M (2011) The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 49:423–429

    Article  PubMed  Google Scholar 

  • Thomas GR, Nadiminti H, Regalado J (2005) Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86:347–363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vainshtein JM, Spector ME, McHugh JB et al (2014) Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol 50:513–519

    Article  PubMed  PubMed Central  Google Scholar 

  • Ward MJ, Thirdborough SM, Mellows T et al (2014) Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer 110:489–500

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands

    Michelle M. Rietbergen, Ruud H. Brakenhoff & C. René Leemans

Authors
  1. Michelle M. Rietbergen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruud H. Brakenhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. René Leemans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. René Leemans .

Editor information

Editors and Affiliations

  1. Department of Head and Neck Surgery, Poznan University of Medical Sciences, The Greater Poland Cancer Centre, Poznań, Poland

    Wojciech Golusiński

  2. Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center/Cancer Center Amsterdam, Amsterdam, The Netherlands

    C. René Leemans

  3. Dept. of Head Medicine and Oral Health, University of Leipzig Clinic of Otolaryngology, Leipzig, Germany

    Andreas Dietz

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rietbergen, M.M., Brakenhoff, R.H., René Leemans, C. (2017). Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC. In: Golusiński, W., Leemans, C., Dietz, A. (eds) HPV Infection in Head and Neck Cancer. Recent Results in Cancer Research, vol 206. Springer, Cham. https://doi.org/10.1007/978-3-319-43580-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43580-0_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43578-7

  • Online ISBN: 978-3-319-43580-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation